Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Melissa Azul DO

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Pediatrics Hematology Oncology Blood and Marrow Transplant

View Curriculum Vitae

Publications (13)

  • EFFECTIVENESS OF HEALTHCARE TRANSITION INTERVENTIONS FOR SICKLE CELL DISEASE. (Azul M, Aurora T, Porter JS, Anderson S, Nelson MN, Ogu UO, Rai P, Persaud Y, Longoria JN, Heitzer AM, Barton M, Olufadi Y, Baumann AA, Kang G, Hankins JS) Blood Adv 2026 Feb 03 PMID: 41632694 02/03/2026    
  • The Pediatric Clinician’s Evidence-based Strategies for Anticipatory Management and Treatment of Acute Pain at Home for Children and Adolescents with Sickle Cell Disease (Azul M, Brandow AM) Pediatric Clinics of North America February 2026;73(1):43-57 SCOPUS ID: 2-s2.0-105017908229 02/01/2026    
  • The Pediatric Clinician's Evidence-based Strategies for Anticipatory Management and Treatment of Acute Pain at Home for Children and Adolescents with Sickle Cell Disease. (Azul M, Brandow AM) Pediatr Clin North Am 2026 Feb;73(1):43-57 PMID: 41207741 SCOPUS ID: 2-s2.0-105017908229 11/10/2025    
  • A mixed methods study to understand the role of knowledge in transition among youth with sickle cell disease. (Singh A, Dasgupta M, Nataliansyah MM, Steiner N, Karst J, Miller M, Field JJ, Azul M, Pezzin LE, Brandow AM) Blood Adv 2025 Sep 09;9(17):4477-4485 PMID: 40554418 PMCID: PMC12410538 SCOPUS ID: 2-s2.0-105014730045 06/24/2025    
  • Resiliency in Child-Caregiver Dyads and the Impact on Health Outcomes in Sickle Cell Disease. (Zavadil JA, Azul M, Carpenter BD, Calhoun C) Children (Basel) 2025 Mar 21;12(4) PMID: 40310076 PMCID: PMC12025687 SCOPUS ID: 2-s2.0-105003406994 05/01/2025       1 Citation
  • Beyond IV push: alternative methods for management of acute pain in SCD. (Azul M, Brandow AM) Hematology Am Soc Hematol Educ Program 2024 Dec 06;2024(1):611-617 PMID: 39644010 PMCID: PMC11665505 SCOPUS ID: 2-s2.0-85212025118 12/07/2024    
  • International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced. (Gupta AO, Azul M, Bhoopalan SV, Abraham A, Bertaina A, Bidgoli A, Bonfim C, DeZern A, Li J, Louis CU, Purtill D, Ruggeri A, Boelens JJ, Prockop S, Sharma A) Cytotherapy 2024 Nov;26(11):1411-1420 PMID: 38970612 PMCID: PMC11471386 SCOPUS ID: 2-s2.0-85198175830 07/06/2024       10 Citations
  • Characterising the prevalence of overweight and obese status among adults with sickle cell disease. (Ibemere SO, Oyedeji CI, Preiss L, Van Althuis LE, Hankins JS, Azul M, Burns EN, Glassberg J, Hagar W, Hussain F, King A, Melvin C, Myers J, Snyder A, Shah N, Tanabe P, Sickle Cell Disease Implementation Consortium) Br J Haematol 2023 Mar;200(5):633-642 PMID: 36382420 PMCID: PMC9957798 SCOPUS ID: 2-s2.0-85142233570 11/17/2022       8 Citations
  • Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19. (Penkert RR, Azul M, Sealy RE, Jones BG, Dowdy J, Hayden RT, Tang L, Ross AC, Hankins JS, Hurwitz JL) Nutrients 2022 Aug 19;14(16) PMID: 36014920 PMCID: PMC9414848 SCOPUS ID: 2-s2.0-85136628826 08/27/2022       4 Citations
  • Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease. (Azul M, Vital EF, Lam WA, Wood DK, Beckman JD) Transl Res 2022 Aug;246:1-14 PMID: 35354090 PMCID: PMC9218997 SCOPUS ID: 2-s2.0-85131651108 03/31/2022       3 Citations
  • Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease. (Geisness AC, Azul M, Williams D, Szafraniec H, De Souza DC, Higgins JM, Wood DK) Haematologica 2022 Jun 01;107(6):1438-1447 PMID: 34706495 PMCID: PMC9152977 SCOPUS ID: 2-s2.0-85131219304 10/29/2021       4 Citations
  • Evidence for complement-mediated bone marrow necrosis in a young adult with sickle cell disease. (Azul M, Shah S, Williams S, Vercellotti GM, Boucher AA) Blood Cells Mol Dis 2021 Feb;86:102508 PMID: 33096468 PMCID: PMC7546691 SCOPUS ID: 2-s2.0-85093666667 10/24/2020       3 Citations
  • Letter to the Editor: A Quality Improvement Initiative for Pediatric Resident Education in Venous Thromboembolism Risk Assessment in Pediatric Patients. (Azul M, Hsu L, Krepel A, Sales JM, Porto I, Hammamieh M) Am J Med Qual 2020;35(4):359-360 PMID: 31581788 SCOPUS ID: 2-s2.0-85089129316 10/05/2019       1 Citation
    • Last update: 03/19/2026